Matrixyl vs. Matrixyl 3000: Palmitoyl Pentapeptide-4 and the Signal Peptides Explained

Matrixyl (palmitoyl pentapeptide-4) has one of the best clinical trials of any cosmetic peptide. Here's how it compares with Matrixyl 3000, Matrixyl synthe'6, hexapeptide-9 and other signal peptides, what the research shows, and how to use them.

By the Glow Cosmetics Editorial Team. Updated .

Quick answer

Matrixyl is palmitoyl pentapeptide-4, a signal peptide modeled on a fragment of collagen. It has one of the strongest single-peptide trials in skincare - a 12-week, double-blind, placebo-controlled study in 93 women that found significant reductions in wrinkles and fine lines. Matrixyl 3000 is a different blend (palmitoyl tripeptide-1 + palmitoyl tetrapeptide-7) that's very widely used but, as far as we could find, has no standalone published efficacy trial; human data show it stays in the outer skin layer.

  • Matrixyl = palmitoyl pentapeptide-4 (pal-KTTKS); Matrixyl 3000 = palmitoyl tripeptide-1 + palmitoyl tetrapeptide-7; Matrixyl synthe'6 = palmitoyl tripeptide-38.
  • Palmitoyl pentapeptide-4 has a 12-week, placebo-controlled RCT (n=93) showing significant wrinkle and fine-line reduction.
  • Matrixyl 3000 is among the most-used peptides but its published human data is mainly a penetration study; most efficacy claims come from supplier data or multi-ingredient products.
  • Signal peptides are gentle and pair well with niacinamide, hydrators and retinol.

If you've read a peptide serum label, you've probably seen "Matrixyl". It's one of the oldest and most-researched peptide families in skincare. But "Matrixyl" covers several different molecules, and the evidence behind each varies a lot. Here's how to tell them apart.

What is a signal peptide?

When skin's support structure (collagen, elastin and the surrounding matrix) breaks down, small protein fragments are released. Researchers found that certain fragments act as signals that prompt skin cells to make more matrix.

Signal peptides are designed to mimic those fragments (Gorouhi & Maibach, 2009). Many carry a palmitoyl group (a fatty acid) to help them move into the oily outer layer of skin. That's why so many of their names start with "palmitoyl".

The Matrixyl family at a glance

Trade name INCI name(s) What it's modeled on Best published human evidence
Matrixyl Palmitoyl pentapeptide-4 (pal-KTTKS) Fragment of type I procollagen 12-week placebo-controlled RCT, n=93
Matrixyl 3000 Palmitoyl tripeptide-1 + palmitoyl tetrapeptide-7 Matrix and inflammation-signaling fragments Penetration study (n=3); multi-ingredient products
Matrixyl synthe'6 Palmitoyl tripeptide-38 Matrix-signaling fragment Uncontrolled multi-ingredient studies

Matrixyl (palmitoyl pentapeptide-4): the strongest evidence

Palmitoyl pentapeptide-4 is built from a five-amino-acid sequence (KTTKS) found in collagen's precursor, with a palmitoyl group attached.

The key trial

In a 12-week, double-blind, placebo-controlled, split-face study of 93 Caucasian women aged 35–55, one side of the face received a moisturizer with 3 ppm palmitoyl pentapeptide-4, and the other the same moisturizer without it (Robinson et al., 2005):

  • Significant reductions in wrinkles and fine lines versus placebo, measured by image analysis and expert grading.
  • Participants also rated the peptide side as significantly improved.
  • It was well tolerated.

Why this trial matters: it's vehicle-controlled (the only difference between sides was the peptide), double-blind, and reasonably large. Very few cosmetic peptides have a trial like it. It was run by scientists from a major skincare company, which is common in this field.

Supporting studies

  • A small 8-week trial of 21 women around the eyes found palmitoyl pentapeptide-4 "appeared to demonstrate better results" than acetyl hexapeptide-3 and placebo (Aruan et al., 2023).
  • Two 4-week split-face studies of products combining palmitoyl pentapeptide-4 with niacinamide, palmitoyl dipeptide and carnosine showed reduced roughness around the eyes. As combination products, they can't isolate the peptide's effect (Kaczvinsky et al., 2009).
  • A 2026 safety framework from the same company found palmitoyl pentapeptide-4 showed homology to collagen-type proteins with no toxin or allergen flags (Bjerke et al., 2026).

Matrixyl 3000: widely used, thinly published

Matrixyl 3000 combines palmitoyl tripeptide-1 (pal-GHK, related to the copper-binding peptide GHK) and palmitoyl tetrapeptide-7 (pal-GQPR). It's one of the most common peptides in anti-aging products: palmitoyl tetrapeptide-7 was among the three most-used peptides in a survey of the market (Ferreira et al., 2020).

What we found in the peer-reviewed literature:

  • A human penetration study (3 volunteers) using tape-stripping and imaging found both peptides throughout the stratum corneum, the outermost skin layer, located between cells, with intensity falling with depth (Trzaska et al., 2026). That's useful, but it shows where the peptides go, not whether they reduce wrinkles.
  • Multi-ingredient products containing this pair have shown benefits; for example, a 12-week eye cream study reported hydration +28% and elasticity +19% (Yang et al., 2024). The peptides' share of that effect can't be separated.
  • No standalone efficacy trial of Matrixyl 3000 turned up in PubMed. The widely quoted wrinkle percentages come from supplier testing.

That doesn't mean Matrixyl 3000 doesn't work, only that its public evidence is thinner than its popularity suggests.

Other signal peptides you'll see

  • Palmitoyl tripeptide-38 (Matrixyl synthe'6): appears in multi-ingredient serums and moisturizers with positive uncontrolled results, such as a 56-day open-label study of a serum that also contained 15% vitamin C (Lintner et al., 2020) and a 12-week open-label moisturizer study in 37 women (Herndon et al., 2015).
  • Hexapeptide-9: a 2025 randomized, double-blind trial of 96 people found a cyclized version beat vehicle and low-dose (0.002%) retinol over 56 days (Chang et al., 2025). Caveats: it's a modified molecule, the retinol comparator was very weak, and the authors were company employees.
  • Tripeptide-10 citrulline (Decorinyl): mimics part of decorin, a protein that organizes collagen fibers. Lab data show more uniform collagen fibrils (Puig et al., 2008), with limited human data in combinations (Raikou et al., 2017).
  • Palmitoyl tripeptide-5 (Syn-Coll): we found no standalone peer-reviewed human trial.

A realistic note on penetration

"Peptides rebuild collagen deep in your skin" is a common claim, but reviews consistently flag penetration as the key limitation. Most peptides are larger than the ~500 dalton size that passes easily through skin (Bos & Meinardi, 2000; Pintea et al., 2025), and the Matrixyl 3000 study found peptides in the outer layer. Signal peptides may work partly by signaling from the upper layers, but the honest framing is gradual, subtle improvement, which is exactly what the best trials show.

How to use Matrixyl peptides

  1. Choose a leave-on serum or moisturizer: peptides need contact time.
  2. Apply once or twice daily after cleansing; serum first, then moisturizer.
  3. Pair with: niacinamide (a proven partner in several peptide trials), hydrators like glycerin and hyaluronate, and sunscreen in the morning.
  4. With retinol: fine together. Use peptides morning and night, and retinol a few evenings a week. See peptides vs. retinol.
  5. Be patient: the key trial measured results at 12 weeks.

Our Multi-Peptide Barrier Cream pairs a peptide duo with ceramides and squalane, and the Copper + Ectoin Peptide Serum is a lightweight daily serum layer.

Frequently asked questions

What is Matrixyl?

Matrixyl is the trade name for palmitoyl pentapeptide-4 (pal-KTTKS), a signal peptide modeled on a fragment of collagen's precursor. A 12-week, placebo-controlled trial in 93 women found it significantly reduced wrinkles and fine lines.

What's the difference between Matrixyl and Matrixyl 3000?

Matrixyl is palmitoyl pentapeptide-4. Matrixyl 3000 is a different blend of palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7. Matrixyl has the stronger published clinical trial; Matrixyl 3000 is more widely used but has thinner published efficacy data.

Is Matrixyl better than retinol?

Retinol has far more research behind it. Matrixyl is gentler and has one good placebo-controlled trial. Many people use both: peptides daily, retinol a few nights a week.

How long does Matrixyl take to work?

The main clinical trial measured significant improvements at 12 weeks of daily use. Give it at least two to three months.

Can I use Matrixyl with vitamin C and niacinamide?

Yes. Signal peptides are generally compatible with vitamin C, niacinamide and hydrators, and several peptide studies used formulas combining peptides with niacinamide.

Does Matrixyl actually build collagen?

Lab research shows signal peptides like palmitoyl pentapeptide-4 can stimulate matrix production by skin cells. In people, the measurable result is a gradual reduction in the appearance of wrinkles; whether peptides reach deep into the dermis is still debated.

Sources

  1. Gorouhi F, Maibach HI. Role of topical peptides in preventing or treating aged skin. Int J Cosmet Sci. 2009;31(5):327-345. https://pubmed.ncbi.nlm.nih.gov/19570099/
  2. Robinson LR, et al. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci. 2005;27(3):155-160. https://pubmed.ncbi.nlm.nih.gov/18492182/
  3. Aruan RR, et al. Double-blind, randomized trial on the effectiveness of acetylhexapeptide-3 cream and palmitoyl pentapeptide-4 cream for crow's feet. J Clin Aesthet Dermatol. 2023;16(2):37-43. https://pubmed.ncbi.nlm.nih.gov/36909866/
  4. Kaczvinsky JR, et al. Efficacy of anti-aging products for periorbital wrinkles as measured by 3-D imaging. J Cosmet Dermatol. 2009;8(3):228-233. https://pubmed.ncbi.nlm.nih.gov/19735523/
  5. Bjerke DL, et al. A framework for the safety evaluation of peptides in cosmetics. Curr Res Toxicol. 2026;10:100291. https://pubmed.ncbi.nlm.nih.gov/41953401/
  6. Ferreira MS, et al. Trending Anti-Aging Peptides. Cosmetics. 2020;7(4):91. https://doi.org/10.3390/cosmetics7040091
  7. Trzaska AH, et al. Permeation behaviour of cosmetic actives into the human stratum corneum. Int J Pharm. 2026:127447. https://pubmed.ncbi.nlm.nih.gov/42790608/
  8. Yang F, et al. Comprehensive evaluation of the efficacy and safety of a new multi-component anti-aging topical eye cream. Skin Res Technol. 2024;30(7):e13790. https://pubmed.ncbi.nlm.nih.gov/38932444/
  9. Lintner K, Gerstein F, Solish N. A serum containing vitamins C & E and a matrix-repair tripeptide reduces facial signs of aging. J Cosmet Dermatol. 2020;19(12):3262-3269. https://pubmed.ncbi.nlm.nih.gov/33103342/
  10. Herndon JH Jr, et al. An open label clinical trial of a multi-ingredient anti-aging moisturizer. J Drugs Dermatol. 2015;14(7):699-704. https://pubmed.ncbi.nlm.nih.gov/26151786/
  11. Chang H, et al. Novel cyclized hexapeptide-9 outperforms retinol against skin aging: a randomized, double-blinded, active- and vehicle-controlled clinical trial. J Cosmet Dermatol. 2025;24(7):e70290. https://pubmed.ncbi.nlm.nih.gov/40586182/
  12. Puig A, Antón JM, Mangues M. A new decorin-like tetrapeptide for optimal organization of collagen fibres. Int J Cosmet Sci. 2008;30(2):97-104. https://pubmed.ncbi.nlm.nih.gov/18377618/
  13. Raikou V, et al. The efficacy study of the combination of tripeptide-10-citrulline and acetyl hexapeptide-3. J Cosmet Dermatol. 2017;16(2):271-278. https://pubmed.ncbi.nlm.nih.gov/28150423/
  14. Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000;9(3):165-169. https://pubmed.ncbi.nlm.nih.gov/10839713/
  15. Pintea A, et al. Peptides: emerging candidates for the prevention and treatment of skin senescence: a review. Biomolecules. 2025;15(1):88. https://pubmed.ncbi.nlm.nih.gov/39858482/